Ozempic, a GLP-1 drug, has been a game-changer for many, including the author, allowing them to enjoy their pregnancy without ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

Consumers are urged to understand which GLP-1 medications are safe, approved, and legal after May 22 If you're one of the ...

Treating nicotine addiction with glucagon-like peptide 1 receptor agonists is associated with less weight gain compared with ...

Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...

Xavier said that patients are often reluctant to quit smoking because they are fearful that they will gain weight. By adding ...

After questions and criticism online, Janelle Rohner says she should have disclosed her decision to take a GLP-1.

And GLP-1 agonists were associated with an 8% lower mortality risk as well (HR 0.92, 95% CI 0.87-0.97), according to findings ...

Veru's pivot with enobosarm: groundbreaking Phase 2b results enhance GLP-1 therapy outcomes. A positive launch could yield ...

New data from digital marketing agency Sagapixel reveals that public interest in the term “GLP-1” has officially surpassed search volume for “Ozempic” — marking a fundamental shift in how patients ...

As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights ...